skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Abstract of Title
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Total Assignments: 3
Patent #:
Issue Dt:
02/20/2024
Application #:
17465344
Filing Dt:
09/02/2021
Publication #:
Pub Dt:
01/20/2022
Inventors:
George R. PAINTER, Gregory R. Bluemling, Michael G. Natchus, David Guthrie
Title:
N4-HYDROXYCYTIDINE AND DERIVATIVES AND ANTI-VIRAL USES RELATED THERETO
Assignment: 1
Reel/Frame:
058557/0480Recorded: 01/05/2022Pages: 8
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignors:
Exec Dt:
05/20/2020
Exec Dt:
05/20/2020
Exec Dt:
05/21/2020
Exec Dt:
05/20/2020
Assignee:
1599 CLIFTON ROAD NE
4TH FLORR
ATLANTA, GEORGIA 30322
Correspondent:
MEUNIER CARLIN & CURFMAN LLC
999 PEACHTREE STREET NE
SUITE 1300
ATLANTA, GA 30309
Assignment: 2
Reel/Frame:
065968/0347Recorded: 12/13/2023Pages: 2
Conveyance:
CONFIRMATORY LICENSE (SEE DOCUMENT FOR DETAILS).
Assignor:
Exec Dt:
10/14/2021
Assignee:
NIH DIVISION OF EXTRAMURAL INVENTIONS AND TECHNOLOGY RESOURCES (DEITR)
6705 ROCKLEDGE DRIVE, SUITE 310, MSC 7980
BETHESDA, MARYLAND 20892-7980
Correspondent:
DIRECTOR, DEITR
NIH, 6705 ROCKLEDGE DRIVE, SUITE 310
MSC 7980
BETHESDA, MD 20892-7980
Assignment: 3
Reel/Frame:
058857/0593Recorded: 01/26/2022Pages: 2
Conveyance:
CONFIRMATORY LICENSE (SEE DOCUMENT FOR DETAILS).
Assignor:
Exec Dt:
11/04/2021
Assignee:
8728 JOHN J KINGMAN ROAD
STOP 6201
FORT BELVOIR, VIRGINIA 66020
Correspondent:
ELLEN KLANN
8725 JOHN J. KINGMAN ROAD
STOP 6201
FORT BELVOIR, VA 22060

Search Results as of: 04/29/2024 03:33 PM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT